HUTCHMED (China) Ltd (HCM) stock
HCMNasdaqPharmaceutical PreparationsAlso trades as HMDCF
$14.90+0.05 (+0.34%)
Close on Nov 13, 2026Market cap $2.60BP/E 5.7Yield –
HUTCHMED (China) ebitda
EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.
HUTCHMED (China)'s ebitda for the twelve months ending Dec 31, 2019 was -$141.44M. For fiscal 2025 it was -$25.85M. The highest annual figure on record is $26.58M in fiscal 2023.
Annual ebitda
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$25.85M | – |
| FY2024 | Dec 31, 2024 | -$31.36M | -218.0% |
| FY2023 | Dec 31, 2023 | $26.58M | – |
| FY2022 | Dec 31, 2022 | -$399.03M | – |
| FY2021 | Dec 31, 2021 | -$321.13M | – |
| FY2020 | Dec 31, 2020 | -$190.61M | – |
| FY2019 | Dec 31, 2019 | -$141.44M | – |
| FY2018 | Dec 31, 2018 | -$89.05M | – |
| FY2017 | Dec 31, 2017 | -$50.84M | – |
| FY2016 | Dec 31, 2016 | -$44.36M | – |
| FY2015 | Dec 31, 2015 | -$7.76M | – |
| FY2014 | Dec 31, 2014 | -$16.99M | – |
Quarterly ebitda
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2019 | Dec 31, 2019 | -$37.13M | – |
| Q3 FY2019 | Sep 30, 2019 | -$34.71M | – |
| Q2 FY2019 | Jun 30, 2019 | -$34.76M | – |
| Q1 FY2019 | Mar 31, 2019 | -$34.85M | – |
| Q4 FY2018 | Dec 31, 2018 | -$23.14M | – |
| Q3 FY2018 | Sep 30, 2018 | -$13.91M | – |
| Q2 FY2018 | Jun 30, 2018 | -$27.81M | – |
| Q1 FY2018 | Mar 31, 2018 | -$24.19M | – |
See a number that looks wrong?